Tokushima, Japan

Jun Matsubara

This inventor holds 9 USPTO granted patents and 8 published patent applications and 3 EPO patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2011-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Matsubara. Retrieved from https://idiyas.com/inventor/jun-matsubara-03uutgc2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 77.8

 

Average Co-Inventor Count = 8.8

ph-index = 3

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2011-2020

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Jun Matsubara: Innovator in Mental Health Treatment

Introduction

Jun Matsubara is a notable inventor based in Tokushima, Japan. She has made significant contributions to the field of mental health treatment through her innovative research and development. With a total of 9 patents to her name, Matsubara is recognized for her dedication to improving therapeutic options for mental disorders.

Latest Patents

One of her latest patents involves piperazine-substituted benzothiophenes for the treatment of mental disorders. This invention provides a heterocyclic compound represented by the general formula (1). The compound has a wide treatment spectrum for mental disorders, including central nervous system disorders, and is noted for having no side effects and high safety.

Career Highlights

Matsubara is currently employed at Otsuka Pharmaceutical Company, Limited, where she continues to advance her research in mental health. Her work is characterized by a commitment to developing safe and effective treatments for patients.

Collaborations

Some of her notable coworkers include Hiroshi Yamashita and Nobuaki Ito, who contribute to her innovative projects and research endeavors.

Conclusion

Jun Matsubara's work in the field of mental health treatment exemplifies her commitment to innovation and patient safety. Her contributions are paving the way for new therapeutic options that can significantly improve the quality of life for individuals with mental disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…